Evidence map›Paper›PMID 23829175›Full record

ArticleCancer science2013

Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.

Toshiyuki Okada, Munetaka Nakamura, Jun Nishikawa, Kouhei Sakai, Yibo Zhang, Mari Saito, Akihiro Morishige, Atsunori Oga, Kosuke Sasaki, Yutaka Suehiro and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cancer science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Toshiyuki OkadaDepartment of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Munetaka Nakamura
Jun Nishikawa
Kouhei Sakai
Yibo Zhang
Mari Saito
Akihiro Morishige
Atsunori Oga
Kosuke Sasaki
Yutaka Suehiro
Yuji Hinoda
Isao Sakaida
Yamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied the comprehensive DNA methylation status in the naturally derived gastric adenocarcinoma cell line SNU-719, which was infected with the Epstein-Barr virus (EBV) by methylated CpG island recovery on chip assay. To identify genes specifically methylated in EBV-associated gastric carcinomas (EBVaGC), we focused on seven genes, TP73, BLU, FSD1, BCL7A, MARK1, SCRN1, and NKX3.1, based on the results of methylated CpG island recovery on chip assay. We confirmed DNA methylation of the genes by methylation-specific PCR and bisulfite sequencing in SNU-719. The expression of the genes, except for BCL7A, was upregulated by a combination of 5-Aza-2'-deoxycytidine and trichostatin A treatment in SNU-719. After the treatment, unmethylated DNA became detectable in all seven genes by methylation-specific PCR. We verified DNA methylation of the genes in 75 primary gastric cancer tissues from 25 patients with EBVaGC and 50 EBV-negative patients who were controls. The methylation frequencies of TP73, BLU, FSD1, BCL7A, MARK1, SCRN1, and NKX3.1 were significantly higher in EBVaGC than in EBV-negative gastric carcinoma. We identified seven genes with promoter regions that were specifically methylated in EBVaGC. Inactivation of these genes may suppress their function as tumor suppressor genes or tumor-associated antigens and help to develop and maintain EBVaGC.

Indexed as

DNA MethylationAgedAzacitidineCarcinomaCell Line, TumorCytoskeletal ProteinsDecitabineDNA-Binding ProteinsDNA, NeoplasmEpstein-Barr Virus InfectionsFemaleGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHomeodomain ProteinsHumansHydroxamic AcidsAzacitidineBCL7A protein, humanCytoskeletal ProteinsDecitabineDNA-Binding ProteinsDNA, NeoplasmFSD1 protein, humanHomeodomain ProteinsHydroxamic AcidsMARK1 protein, humanMicrofilament ProteinsNeoplasm ProteinsNerve Tissue ProteinsNKX3-1 protein, humanNuclear ProteinsOncogene ProteinsProtein Serine-Threonine KinasesRNA, MessengerRNA, NeoplasmSCRN1 protein, humanTP73 protein, humanTranscription Factorstrichostatin ATumor Protein p73Tumor Suppressor ProteinsZMYND10 protein, human

Identifiers

PMID23829175
PMCPMC7656552
OpenAlexW2027639664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.